Interpace Biosciences Market Cap

Interpace Biosciences has a market cap or net worth of $6.35 million as of April 19, 2024. Its market cap has decreased by -81.71% in one year.

Market Cap

6.35M

Enterprise Value

14.04M

1-Year Change

-81.71%

Ranking

n/a

Market Cap Chart

Since December 1, 1998, Interpace Biosciences's market cap has decreased from $240.50M to $6.35M, a decrease of -97.36%. That is a compound annual growth rate of -15.07%.

Market Cap History

Date	Market Cap	% Change
Feb 24, 2021	15.90M	0.63%
Feb 23, 2021	15.80M	-8.14%
Feb 22, 2021	17.20M	-1.15%
Feb 19, 2021	17.40M	5.45%
Feb 18, 2021	16.50M	-8.33%
Feb 17, 2021	18.00M	-24.05%
Feb 16, 2021	23.70M	1.28%
Feb 12, 2021	23.40M	2.63%
Feb 11, 2021	22.80M	3.17%
Feb 10, 2021	22.10M	-4.33%
Feb 9, 2021	23.10M	7.44%
Feb 8, 2021	21.50M	9.14%
Feb 5, 2021	19.70M	-3.90%
Feb 4, 2021	20.50M	-
Feb 3, 2021	20.50M	19.88%
Feb 2, 2021	17.10M	-2.84%
Feb 1, 2021	17.60M	7.98%
Jan 29, 2021	16.30M	-5.23%
Jan 28, 2021	17.20M	1.78%
Jan 27, 2021	16.90M	-6.11%
Jan 26, 2021	18.00M	3.45%
Jan 25, 2021	17.40M	6.75%
Jan 22, 2021	16.30M	-4.12%
Jan 21, 2021	17.00M	-3.41%
Jan 20, 2021	17.60M	-4.86%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly	713.81B
Novo Nordisk	564.13B
UnitedHealth Group	441.60B
Johnson & Johnson	348.72B
Merck & Co.	317.52B
AbbVie	290.83B
AstraZeneca	212.43B
Thermo Fisher	208.89B

Market Cap Rankings